Genetic testing decision support for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study tests a tool to help prostate cancer patients understand and decide about genetic testing. It is designed for patients at LBJ Hospital who have been recommended for testing by their doctor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with prostate cancer
- Currently receiving care at Lyndon B. Johnson (LBJ) Hospital
- Your doctor has recommended germline genetic testing
- Can speak and understand English or Spanish
- Will not participate if you have a serious mental or thinking condition that prevents you from taking part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a community health coach to help Black men with prostate cancer understand and access genetic testing that looks for inherited cancer risk. It may help you talk with your care team about testing and reduce barriers to getting results.
This study collects saliva and health/family history information to learn how inherited (genetic) factors relate to prostate cancer. The goal is to improve how treatment and future screening are planned for people and families.
This study looks at how Veterans with advanced prostate cancer make decisions about gene testing and possible targeted treatments, and how patients and caregivers understand the information. It may help by improving decision support for people facing germline and tumor testing choices.
This study looks at how patients and doctors feel about genetic testing for prostate cancer. It aims to improve how genetic risk information is shared and understood.
This study tests a new tool to help Black or African American men with prostate cancer understand genetic testing options. The goal is to improve counseling and decision-making about tumor genetic testing.
This study offers free genetic testing to cancer patients and their healthcare providers. It aims to help people who may not have easy access to genetic testing understand their cancer risk.
Hear when a new Prostate Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.